Phensuximide

Phensuximide (CAS No.: 86-34-0) is a synthetic small molecule in the succinimide class that is broadly categorized as a neuropharmacology research reagent and historical anticonvulsant chemotype used to investigate mechanisms of neuronal hyperexcitability in preclinical systems, with reported functional activity including suppression of cyclic AMP and cyclic GMP accumulation in depolarized brain tissue and a mechanistic profile commonly interpreted as modulation of membrane excitability and seizure related signaling rather than highly selective engagement of a single molecular target; in biomedical research and drug discovery workflows, it is therefore primarily positioned as a reference compound for central nervous system assay calibration, pathway interrogation in excitability associated models, and comparative phenotypic screening against newer ion channel or neurotransmission focused candidates, while quantitative potency metrics such as IC50 or EC50 are not consistently established in standardized modern formats for this specific molecule and are generally treated as context dependent, with observed effects typically evaluated across micromolar to higher concentration domains in legacy or exploratory paradigms depending on assay configuration, species, tissue preparation, and stimulation conditions; typical use cases include in vitro neuronal or brain slice based electrophysiology and second messenger studies, as well as in vivo seizure susceptibility models for translational pharmacology benchmarking, where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, and all use is limited to controlled laboratory research settings only.